亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Prophylaxis or Treatment of Feline Coronavirus Infection

詳細技術說明
This technology describes a novel method that may offer a cure forfeline infectious peritonitis virus (FIPV).
*Abstract

Feline coronavirus (FCoV) infection in >90% of infected cats results in only mild and often inapparent enteritis. This form of FCoV is referred to as feline enteric coronavirus (FECV). However, in a small number of animals, FECV mutates into a form that confers it with the ability to infect macrophages and monocytes. It is this mutated form of the virus, called feline infectious peritonitis virus (FIPV) that leads to feline infectious peritonitis (FIP) - a lethal infection in cats and the most feared disease in catteries, for which there is no effective treatment.

 

Cornell researchers have developed a novel treatment paradigm for FIP and suppression of FCoV infection more generally. Specifically, differential cleavage by different cysteine proteases of the viral spike protein involved in viral entry was shown to be a critical factor in explaining the different pathogenic properties of FECV and FIPV. As such, FIPV treatment and suppression of FCoV infections more generally may be possible using cysteine protease inhibitors that target specific cysteine proteases.

 

Potential Applications

Treatment of FCoV and FIPV infection in cats

 

For more details, you arewelcome to download the technology brief.

*Licensing
Phillip Owhpo62@cornell.edu607-254-4508
其他
  • U.S.patent number 9,044,486.
  • ReganAD & al. (2008). Differential role for low pH and cathepsin-mediatedcleavage of the viral spike protein during entry of serotype II felinecoronaviruses. Vet Microbiol. Dec10;132(3-4):235-48. doi: 10.1016/j.vetmic.2008.05.019.

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備